Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2023 Feb 15;133(4):e169299. doi: 10.1172/JCI169299

IL-10–producing Th1 cells possess a distinct molecular signature in malaria

Chelsea L Edwards, Susanna S Ng, Fabian de Labastida Rivera, Dillon Corvino, Jessica A Engel, Marcela Montes de Oca, Luzia Bukali, Teija CM Frame, Patrick T Bunn, Shashi Bhushan Chauhan, Siddharth Sankar Singh, Yulin Wang, Jinrui Na, Fiona H Amante, Jessica R Loughland, Megan SF Soon, Nicola Waddell, Pamela Mukhopadhay, Lambros T Koufariotis, Rebecca L Johnston, Jason S Lee, Rachel Kuns, Ping Zhang, Michelle J Boyle, Geoffrey R Hill, James S McCarthy, Rajiv Kumar, Christian R Engwerda
PMCID: PMC9927919  PMID: 36787259

Original citation: J Clin Invest. 2023;133(1):e153733. https://doi.org/10.1172/JCI153733

Citation for this corrigendum: J Clin Invest. 2023;133(4):e169299. https://doi.org/10.1172/JCI169299

The title of this paper was incorrect. The correct title is above. The HTML and PDF versions have been updated online.

The authors regret the error.

Version 1. 02/15/2023

Electronic publication

Footnotes


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES